Rönninge, Sweden

Ulf A Kjellberg

This inventor holds 1 USPTO granted patent. Top assignee: Astra Lakemedel Aktiebolag. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulf A Kjellberg. Retrieved from https://idiyas.com/inventor/ulf-a-kjellberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulf A Kjellberg: Innovator in Pharmaceutical Stabilization

Introduction

Ulf A Kjellberg is a notable inventor based in Ronninge, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of medications. His innovative approach has led to advancements that benefit the pharmaceutical industry.

Latest Patents

Kjellberg holds a patent for a process aimed at stabilizing bacampicillin hydrochloride. This new process is characterized by the incorporation of between 3 to 9% by weight of straight-chain alkanes, alkenes, fatty acids, alcohols, and esters of fatty acids and alcohols with molecular weights between 144 and 350. The process can be executed in one step alongside wet-massing for granulation, effectively protecting the compound against degradation by humidity.

Career Highlights

Ulf A Kjellberg is associated with Astra Lakemedel Aktiebolag, where he has applied his expertise in pharmaceutical development. His work has been instrumental in enhancing the stability and efficacy of various medications.

Collaborations

Kjellberg has collaborated with notable colleagues such as Per Gustaf Nyqvist and Jan U Stenhede. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ulf A Kjellberg's contributions to pharmaceutical stabilization demonstrate his commitment to improving medication efficacy. His innovative processes continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…